Recent Deals & Cases

  • Datac Instrumentation Limited and RealFlex Technologies Limited

    Advised Datac Instrumentation Limited and RealFlex Technologies Limited on their sale to Lufkin Industries, Inc.

  • Cúram Software Limited

    Advised the shareholders of Cúram Software Limited on its sale to IBM. 

  • Allied Irish Banks plc

    Advised Allied Irish Banks plc on the sale of AIB Asset Management Holdings (Ireland) to Prescient Holdings (PTY) Limited.   

  • Blackrock Investment Management (UK) Limited

    Advising BlackRock Investment Management (UK) Limited in its capacity as holder of approximately 9.3% of the shares of Clearstream Technologies Group plc in respect of the acquisition by Hastings Investments Ireland Limited of Clearstream.

  • Green Property

    Advised Green Property on its joint venture with Lloyds Bank plc under which Green Property will manage Irish commercial properties put into the receivership process by Bank of Scotland (Ireland).       

  • Merrion Capital Holdings Limited

    Advised Merrion Capital Holdings Limited on the recently completed share exchange with US Investment Bank, Teneo Capital LLC

  • ACRA Control Limited

    Advised ACRA Control Limited, the Dublin-based aerospace company and its shareholders, on the €46m sale of its entire issued share capital to Curtiss-Wright Controls (UK) Limited, a UK subsidiary of Curtiss-Wright Controls, Inc.

  • Jacob Fruitfield Food Group Limited

    Advised the shareholders of Jacob Fruitfield Food Group Limited on the sale of the entire issued share capital of Jacob Fruitfield Food Group Limited to Valeo Foods and on their acqusiition of a strategic stake in Valeo Food Group Limited.

  • Fairfax Financial Holdings Limited

    Advised the lead investors, including Fairfax Financial Holdings Limited, WL Ross, Kennedy Wilson and others on the €1.1bn purchase of a 34% stake in Bank of Ireland from the Irish Government.

  • BioMarin Pharmaceuticals Inc

    Advised BioMarin Pharmaceuticals Inc on its agreement to buy a bulk biologics manufacturing plant from Pfizer for US$48.5m.